NLTX Annual Non Current Assets
$16.81 M
-$2.46 M-12.76%
31 December 2022
Summary:
As of February 5, 2025, NLTX annual long term assets is $16.81 million, with the most recent change of -$2.46 million (-12.76%) on December 31, 2022. During the last 3 years, it has risen by +$13.39 million (+390.63%).NLTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly Non Current Assets
$9.69 M
-$532.00 K-5.20%
30 September 2023
Summary:
As of February 5, 2025, NLTX quarterly long term assets is $9.69 million, with the most recent change of -$532.00 thousand (-5.20%) on September 30, 2023. Over the past year, it has dropped by -$8.03 million (-45.30%).NLTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.8% | -45.3% |
| 3 y3 years | +390.6% | -35.8% |
| 5 y5 years | +1018.0% | +1760.5% |
NLTX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -67.0% | -81.0% |
Neoleukin Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $9.69 M(-5.2%) |
| June 2023 | - | $10.22 M(-20.3%) |
| Mar 2023 | - | $12.82 M(-23.7%) |
| Dec 2022 | $99.13 M(-31.2%) | $16.81 M(-5.1%) |
| Sept 2022 | - | $17.72 M(-4.4%) |
| June 2022 | - | $18.54 M(-1.2%) |
| Mar 2022 | - | $18.76 M(-2.7%) |
| Dec 2021 | $143.99 M(-26.0%) | $19.27 M(-0.8%) |
| Sept 2021 | - | $19.44 M(-0.5%) |
| June 2021 | - | $19.53 M(+3.9%) |
| Mar 2021 | - | $18.80 M(+17.5%) |
| Dec 2020 | $194.52 M(+35.5%) | $16.00 M(+5.9%) |
| Sept 2020 | - | $15.10 M(+5.4%) |
| June 2020 | - | $14.33 M(+6.9%) |
| Mar 2020 | - | $13.40 M(+291.0%) |
| Dec 2019 | $143.60 M(+86.1%) | $3.43 M(+55.1%) |
| Sept 2019 | - | $2.21 M(+313.7%) |
| June 2019 | - | $534.00 K(-11.4%) |
| Mar 2019 | - | $603.00 K(+33.1%) |
| Dec 2018 | $77.17 M | $453.00 K(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $521.00 K(-56.0%) |
| June 2018 | - | $1.19 M(-15.4%) |
| Mar 2018 | - | $1.40 M(-6.9%) |
| Dec 2017 | $108.83 M(+5.2%) | $1.50 M(+46.2%) |
| Sept 2017 | - | $1.03 M(-5.8%) |
| June 2017 | - | $1.09 M(-94.8%) |
| Mar 2017 | - | $20.89 M(-58.9%) |
| Dec 2016 | $103.48 M(+38.4%) | $50.90 M(+191.5%) |
| Sept 2016 | - | $17.46 M(-47.2%) |
| June 2016 | - | $33.05 M(-14.7%) |
| Mar 2016 | - | $38.73 M(+0.5%) |
| Dec 2015 | $74.80 M(+90.3%) | $38.55 M(>+9900.0%) |
| Sept 2015 | - | $93.00 K(-4.1%) |
| June 2015 | - | $97.00 K(-11.0%) |
| Mar 2015 | - | $109.00 K(-94.9%) |
| Dec 2014 | $39.30 M(+156.9%) | $2.12 M(-74.3%) |
| Sept 2014 | - | $8.25 M(-50.4%) |
| June 2014 | - | $16.62 M(+8099.7%) |
| Mar 2014 | - | $202.70 K(-42.5%) |
| Dec 2013 | $15.30 M(+641.1%) | $352.80 K |
| Dec 2012 | $2.06 M | - |
FAQ
- What is Neoleukin Therapeutics annual long term assets?
- What is the all time high annual non current assets for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual non current assets year-on-year change?
- What is Neoleukin Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly non current assets year-on-year change?
What is Neoleukin Therapeutics annual long term assets?
The current annual non current assets of NLTX is $16.81 M
What is the all time high annual non current assets for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual long term assets is $50.90 M
What is Neoleukin Therapeutics annual non current assets year-on-year change?
Over the past year, NLTX annual long term assets has changed by -$2.46 M (-12.76%)
What is Neoleukin Therapeutics quarterly long term assets?
The current quarterly non current assets of NLTX is $9.69 M
What is the all time high quarterly non current assets for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly long term assets is $50.90 M
What is Neoleukin Therapeutics quarterly non current assets year-on-year change?
Over the past year, NLTX quarterly long term assets has changed by -$8.03 M (-45.30%)